FrancophonIA/ELRC3.0 huggingface dataset:
English: Because Ibandronic acid Accord is a generic medicine, its benefits and risks are taken as being the same as the reference medicines'.
Estonian: Et Ibandronic acid Accord on geneeriline ravim, peetakse ravimi kasulikkust ja riske samadeks mis võrdlusravimitel.
English: Patients with moderate or severe kidney problems should receive Ibandronic acid Accord infusions at a lower dose over an hour.
Estonian: Mõõdukate või raskete neeruprobleemidega patsientidele manustatakse ravimit Ibandronic acid Accord üle 1 tunni kestva väiksemas annuses infusioonina.
English: For the treatment of osteoporosis, Ibandronic acid Accord is given as an injection into a vein once every three months.
Estonian: Osteoporoosi raviks manustatakse ravimit Ibandronic acid Accord veenisüstina üks kord iga kolme kuu järel.
English: The Agency recommended that Ibandronic acid Accord be approved for use in the EU.
Estonian: EMA soovitas ravimi Ibandronic acid Accord kasutamise Euroopa Liidus heaks kiita.
English: Ibandronic acid Accord is available as a solution for injection (3 mg) in a pre-filled syringe and as a concentrate (2 mg and 6 mg) to be made up into a solution for infusion (drip) into a vein.
Estonian: Ravimit Ibandronic acid Accord turustatakse süstelahusena (3 mg) eeltäidetud süstlas ja infusioonilahuse (veeni tilgutatava lahuse) valmistamise kontsentraadina (2 mg ja 6 mg).
English: Ibandronic acid Accord is a medicine used to treat certain conditions affecting bones and blood calcium.
Estonian: Ravimit Ibandronic acid Accord kasutatakse luude ja vere kaltsiumisisalduse teatud seisundite raviks.
English: In the prevention of skeletal events in patients with breast cancer and bone metastases, Ibandronic acid Accord is given into a vein as a 6 mg infusion lasting at least 15 minutes every three to four weeks.
Estonian: Luukahjustuste ennetamiseks manustatakse rinnavähi ja luumetastaasidega patsientidele ravimit Ibandronic acid Accord vähemalt 15 minutit kestva 6 mg veeniinfusioonina iga kolme või nelja nädala järel.
English: For practical information about using Ibandronic acid Accord, patients should read the package leaflet or contact their doctor or pharmacist.
Estonian: Kui vajate ravimi Ibandronic acid Accord kasutamise praktilisi nõuandeid, lugege pakendi infolehte või pöörduge oma arsti või apteekri poole.
English: The company that markets Ibandronic acid Accord will provide a card to inform patients receiving Ibandronic acid Accord infusion about the risk of osteonecrosis of the jaw and to instruct them to contact their doctor if they get symptoms.
Estonian: Ravimi Ibandronic acid Accord turustaja varustab patsiendid teabekaardiga, milles selgitatakse lõualuu osteonekroosi riski ning soovitatakse sümptomite tekkimisel pöörduda arsti poole.
English: In the treatment of hypercalcaemia caused by tumours, Ibandronic acid Accord is given into a vein as an infusion of 2 or 4 mg, depending on how severe the hypercalcaemia is.
Estonian: Kasvaja põhjustatud hüperkaltseemia raviks manustatakse ravimit Ibandronic acid Accord 2 mg või 4 mg veeniinfusioonina olenevalt sellest, kas hüperkaltseemia on mõõdukas või raske.
English: For more information about treatment with Ibandronic acid Accord, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Estonian: Kui vajate ravimiga Ibandronic acid Accord toimuva ravi kohta lisateavet, lugege palun pakendi infolehte (mis on samuti Euroopa avaliku hindamisaruande osa) või pöörduge oma arsti või apteekri poole.
English: By preventing the breakdown of bones, Ibandronic acid Accord also helps to reduce the amount of calcium released into the blood.
Estonian: Luukoe lagunemist peatades aitab Ibandronic acid Accord vähendada verre eralduva kaltsiumi kogust.
English: What is Ibandronic acid Accord and what is it used for?
Estonian: Mis on Ibandronic acid Accord ja milleks seda kasutatakse?
English: Other information about Ibandronic acid Accord
Estonian: Muu teave ravimi Ibandronic acid Accord kohta
English: It is not intended to provide practical advice on how to use Ibandronic acid Accord.
Estonian: Hindamisaruandes ei anta ravimi Ibandronic acid Accord kasutamise praktilisi nõuandeid.
English: Ibandronic acid Accord contains the active substance ibandronic acid and is a ‘generic medicine'.
Estonian: Ibandronic acid Accord sisaldab toimeainena ibandroonhapet ja see on geneeriline ravim.
English: Ibandronic acid Accord concentrate for solution for infusion (drip) is used in adults to:
Estonian: Ravimi Ibandronic acid Accord infusioonilahuse kontsentraati kasutatakse järgmiste seisundite raviks täiskasvanutel:
English: The reference medicines for Ibandronic acid Accord are Bondronat and Bonviva.
Estonian: Ravimi Ibandronic acid Accordi võrdlusravimid on Bondronat ja Bonviva.
English: This is a summary of the European public assessment report (EPAR) for Ibandronic acid Accord.
Estonian: See on ravimi Ibandronic acid Accord Euroopa avaliku hindamisaruande kokkuvõte.
English: It stops the action of osteoclasts, the cells in the body that are involved in breaking down the bone tissue.
Estonian: Toimeaine peatab osteoklastide ehk luukoe lagundamisel osalevate organismirakkude tegevuse.
English: Therefore, the Agency's view was that, as for Bondronat and Bonviva, the benefit outweighs the identified risk.
Estonian: Seetõttu on amet arvamusel, et nagu ka Bondronati ja Bonviva korral, ületab ravimi Ibandronic acid Accord kasulikkus sellega kaasnevad riskid.
English: Why is Ibandronic acid Accord approved?
Estonian: Miks Ibandronic acid Accord heaks kiideti?
English: Ibandronic acid Accord ibandronic acid
Estonian: Ibandronic acid Accord ibandroonhape
English: Ibandronic acid Accord solution for injection is used to treat osteoporosis (a disease that makes bones fragile) in women who have been through the menopause and are at risk of developing bone fractures (breaks).
Estonian: Ravimi Ibandronic acid Accord süstelahust kasutatakse osteoporoosi (luu-urbnemuse) raviks menopausijärgses eas naistel, kellel on luumurru tekke risk.
English: There was no need for ‘bioequivalence' studies to investigate whether Ibandronic acid Accord is absorbed similarly to the reference medicines to produce the same level of the active substance in the blood.
Estonian: Ravimi bioekvivalentsust (kas Ibandronic acid Accord imendub organismis samamoodi nagu võrdlusravimid, et saavutada toimeaine sarnane sisaldus veres) ei olnud vaja uurida, sest ravimit Ibandronic acid Accord manustatakse veeniinfusioonina, mille abil satub toimeaine otse vereringesse.
English: How does Ibandronic acid Accord work?
Estonian: Kuidas Ibandronic acid Accord toimib?
English: The active substance in Ibandronic acid Accord, ibandronic acid, is a bisphosphonate.
Estonian: Ravimi Ibandronic acid Accord toimeaine ibandroonhape on bisfosfonaat.
English: How has Ibandronic acid Accord been studied?
Estonian: Kuidas ravimit Ibandronic acid Accord uuriti?
English: How is Ibandronic acid Accord used?
Estonian: Kuidas ravimit Ibandronic acid Accord kasutatakse?
English: What are the benefits and risks of Ibandronic acid Accord?
Estonian: Milles seisneb ravimi Ibandronic acid Accord kasulikkus ja mis riskid ravimiga kaasnevad?
English: • are older than 65 years or if you have problems with your kidneys.
Estonian: • olete vanem kui 65-aastane või kui teil on neeruprobleemid.
English: DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 06 April 2010
Estonian: ESMASE MÜÜGILOA VÄLJSTAMISE/MÜÜGILOA UUENDAMISE KUUPÄEV Esmase müügiloa väljastamise kuupäev: 6. aprill 2010
English: This should be discussed with your doctor.
Estonian: Seda tuleb arutada oma arstiga.
English: Therefore, your blood will be checked regularly to be sure that the HIV infection is not getting worse.
Estonian: Seetõttu kontrollitakse regulaarselt teie verd, tagamaks, et HIV-infektsioon ei muutu halvemaks.
English: Biopartners GmbH Kaiserpassage 11 D-72764 Reutlingen Germany
Estonian: Biopartners GmbH Kaiserpassage 11 D-72764 Reutlingen Saksamaa
English: You should tell your doctor if you have suffered from any other serious illness in the past.
Estonian: Peate rääkima oma arstile, kui teil on varem olnud ükskõik milline raske haigus.
English: < 12 g/dl after 4 weeks of dose reduction
Estonian: < 12 g/dl 4 nädalat pärast annuse vähendamist
English: - Lactation.
Estonian: - Imetamine.
English: The application is based on a reference medicinal product for which no safety concerns requiring additional risk minimization activities have been identified.
Estonian: Taotlus põhineb viidataval ravimil, millele ei ole kindlaks tehtud mingeid ohutust puudutavaid küsimusi, mis nõuaksid täiendavaid tegevusi riski minimeerimiseks.
English: Read across on the same line to see how many tablets to take.
Estonian: Samalt realt lugege, mitu tabletti võtta.
English: - Pregnant women (see sections 4.4, 4.6 and 5.3).
Estonian: - Rasedus (vt lõigud 4.4, 4.6 ja 5.3).
English: The MAH must ensure that the system of pharmacovigilance, as described in version 5 dated 27 April 2009 presented in Module 1.8.2 of the Marketing Authorisation Application, is in place and functioning before and whilst the product is on the market.
Estonian: Müügiloa hoidja peab tagama, et ravimiohutuse järelevalve süsteem, nagu on kirjeldatud müügiloa Taotlus moodulis 1.8.2 esitatud versioonis 5 kuupäevaga 27. aprill 2009, on loodud ja toimib enne toote turuletulekut ja toote turustamise ajal.
English: Based on the results of clinical trials, it is recommended that patients be treated for at least six months.
Estonian: Kliiniliste uuringute tulemuste põhjal soovitatakse patsiente ravida vähemalt 6 kuud.
English: If you have this reaction, be sure to rinse your mouth thoroughly afterwards.
Estonian: Kui teil tekib selline reaktsioon, loputage kindlasti pärast oksendamist hoolikalt suu.
English: Some children did not reach their projected height within 1-5 years after completing treatment.
Estonian: Mõned lapsed ei saavutanud oma oodatavat kehapikkust 1…5 aasta jooksul pärast ravi lõpetamist.
English: Whenever possible the child should be treated after the pubertal growth spurt, in order to reduce the risk of growth inhibition.
Estonian: Kui vähegi võimalik, tuleks last ravida pärast puberteediea kasvuspurti, et vähendada kasvu pidurdumise riski.
English: EU/1/10/626/001 (84 film-coated tablets) EU/1/10/626/002 (112 film-coated tablets) EU/1/10/626/003 (140 film-coated tablets) EU/1/10/626/004 (168 film-coated tablets)
Estonian: EU/1/10/626/001 (84 õhukese polümeerikattega tabletti) EU/1/10/626/002 (112 õhukese polümeerikattega tabletti) EU/1/10/626/003 (140 õhukese polümeerikattega tabletti) EU/1/10/626/004 (168 õhukese polümeerikattega tabletti)
English: Adult patients:
Estonian: Täiskasvanud patsiendid
English: The attempt to harm yourself has also been reported in adults, children, and adolescents.
Estonian: Enda vigastamise püüe esines ka täiskasvanutel, lastel ja noorukitel.
English: The usual dose, according to how much the patient weighs, is shown in the table below: Look for the line that shows how much the adult or child/adolescent weighs.
Estonian: Tavaline annus, sõltuvalt sellest, kui palju patsient kaalub, on näidatud allolevas tabelis: Otsige rida, mis näitab, kui palju täiskasvanu või laps/nooruk kaalub.
English: • have any severe medical conditions that leave you very weak, including severe kidney disease.
Estonian: • teil on mingi raske meditsiiniline seisund, mis muudab teid väga nõrgaks, sealhulgas raske neeruhaigus;
English: Ribavirin BioPartners can be very damaging to your unborn baby (embryo).
Estonian: Ribavirin BioPartners võib olla väga kahjulik teie sündimata lapsele (lootele).
English: When deciding to not to defer treatment until adulthood, it is important to consider that the combination therapy induced a growth inhibition.
Estonian: Kui otsustatakse ravi mitte edasi lükata täiskasvanueani, on tähtis arvestada, et kombinatsioonravi on põhjustanud kasvu pärssimist.
English: If it gets worse, your doctor will decide whether or not your Ribavirin BioPartners treatment needs to be changed.
Estonian: Kui see siiski halveneb, otsustab teie arst, kas ravi Ribavirin BioPartners'iga tuleb muuta.
English: Ribavirin BioPartners is available in different pack sizes containing 84, 112, 140 or 168 film-coated tablets.
Estonian: Ribavirin BioPartners on saadaval erineva suurusega pakendites, mis sisaldavad 84, 112, 140 või 168
English: - Depending upon the results of these tests, your doctor may change/adjust the number of tablets you or the child you are caring for take, prescribe a different pack size of Ribavirin BioPartners, and/or change the length of time to take this treatment.
Estonian: - Sõltuvalt nende analüüside tulemustest võib arst muuta/kohandada teie või teie eestkostel oleva lapse poolt võetavate tablettide arvu, kirjutada välja teistsuguse pakendi suurusega Ribavirin BioPartners'i ja/või muuta ravi ajalist kestust.
English: Children 3 years of age and older and adolescents:
Estonian: 3-aastased või vanemad lapsed ja noorukid:
English: This will lessen the possibility for ribavirin to be left in the woman's body.
Estonian: See vähendab ribaviriini naise organismi jätmise võimalust.
English: Do not use Ribavirin BioPartners without advice of your doctor or pharmacist if you notice any change in the appearance of the tablets.
Estonian: Ärge kasutage Ribavirin BioPartners'it enne arstilt või apteekrilt nõu küsimata, kui te märkate mingeid muutusi tablettide välimuses.
English: The choice of combination regimen is based on the characteristics of the patient.
Estonian: Kombinatsioonravi režiimi valik sõltub patsiendi näitajatest.
English: Always take Ribavirin BioPartners exactly as your doctor has told you.
Estonian: Võtke Ribavirin BioPartners'it alati täpselt nii, nagu arst on teile rääkinud.
English: have suffered from autoimmune disease in the past, or suffer from autoimmune hepatitis, or are taking other medicines that suppress your immune system (that protects you against infection and some diseases).
Estonian: • teil on varem olnud autoimmuunhaigus või teil on autoimmuunne hepatiit või te võtate muid ravimeid, mis suruvad alla teie immuunsüsteemi (see kaitseb teid nakkuste ja teatud haiguste eest)
English: Reminder: If your doctor's instructions are different from the amounts in the below table,
Estonian: Pea meeles: Kui arsti juhised erinevad kogustest allolevas tabelis, järgi oma arsti juhiseid.
English: Thus, patients who develop fatigue, somnolence, or confusion during treatment must be cautioned to avoid driving or
Estonian: Seega tuleb patsientidel, kes tunnevad ravi ajal väsimust, unisust või segasust, soovitada vältida autojuhtimist
English: • have had any previous severe heart problems, or have had any problems with the heart in the last 6 months.
Estonian: • teil on varem olnud ükskõik milliseid raskeid südameprobleeme või ükskõik milliseid südameprobleeme viimase 6 kuu jooksul;
English: Adults: ≥ 12 g/dl (females); ≥ 13 g/dl (males) Children and adolescents: ≥ 11 g/dl (females); ≥ 12 g/dl (males)
Estonian: Täiskasvanud: ≥ 12 g/dl (naistel); ≥ 13 g/dl (meestel) Lapsed ja noorukid: ≥ 11 g/dl (naistel); ≥ 12 g/dl (meestel)
English: Growth rate decrease (height and/or weight decrease for age)
Estonian: Kasvukiiruse vähenemine (vanusele vastava kasvu ja/või
English: The response to treatment in both of these trials is presented in Table 7.
Estonian: Ravivastus, mida täheldati mõlemas uuringus, on toodud Tabelis 7.
English: You should tell your doctor if you or your child you are caring for:
Estonian: Rääkige oma arstile, kui teie või teie laps:
English: Nucleoside analogs: Use of nucleoside analogs, alone or in combination with other nucleosides, has resulted in lactic acidosis.
Estonian: Nukleosiidide analoogid: Nukleosiidide analoogide kasutamine üksi või kombinatsioonis teiste nukleosiididega on põhjustanud laktatsidoosi teket.
English: If you take more Ribavirin BioPartners than you should Tell your doctor or pharmacist as soon as possible.
Estonian: Kui te võtate Ribavirin BioPartners'it rohkem kui ette nähtud Informeerige niipea kui võimalik oma arsti või apteekrit.
English: You or your female partner must use an effective contraceptive during the time you are taking Ribavirin BioPartners and for 7 months after stopping treatment.
Estonian: Teie või teie naispartner peate kasutama efektiivset rasestumisvastast vahendit Ribavirin BioPartners'i võtmise ajal ja 7 kuu jooksul pärast ravi lõppu.
English: Note: For patients who weigh < 47 kg, or are unable to swallow tablets, ribavirin oral solution is available and should be used if appropriate.
Estonian: Märkus: Patsientide puhul, kes kaaluvad < 47 kg või ei ole võimelised tablette neelama, on saadaval ribaviriini suukaudne lahus ja seda tuleb vajadusel kasutada.
English: 3 tablets a
Estonian: 3 tablettia
English: Packs of 84, 112, 140 and 168 film-coated tablets.
Estonian: Pakendis on 84, 112, 140 ja 168 õhukese polümeerikattega tabletti.
English: If an entire day has gone by, check with your doctor.
Estonian: Kui on möödunud terve päev, pidage nõu oma arstiga.
English: Ribavirin was active in the Balb/3T3 in vitro Transformation Assay.
Estonian: Ribaviriin oli aktiivne Balb/3T3 in vitro transformatsiooni analüüsis.
English: The adverse reactions listed in Table 4 are based on experience from clinical trials in adult naïve patients treated for 1 year and post-marketing use.
Estonian: Kõrvaltoimed, mis on loetletud tabelis 4 põhinevad kogemustele kliinilistest uuringutest täiskasvanud varem ravi mittesaanud patsientidel, keda raviti 1 aasta jooksul ning turustamisjärgsest kasutamisest.
English: If pregnancy does occur during treatment or within four months from stopping treatment, the patient must be advised of the significant teratogenic risk of ribavirin to the foetus.
Estonian: Kui rasestumine toimub ravi ajal või 4 kuu jooksul pärast ravi lõppu, tuleb patsienti teavitada ribaviriini märkimisväärsest teratogeensuse riskist lootele.
English: Reminder: If the child is under the age of 3 years, do not administer.
Estonian: Pea meeles: Ära manusta, kui laps on noorem kui 3-aastane.
English: Ribavirin is a synthetic nucleoside analogue which has shown in vitro activity against some RNA and DNA viruses.
Estonian: Ribaviriin on sünteetiline nukleosiidi analoog, mis on in vitro tõestatult mõnede RNA- ja DNA-viiruste vastase aktiivsusega.
English: Patients with low CD4 counts:
Estonian: Patsiendid madala CD4-rakkude arvuga:
English: Ribavirin BioPartners stops the multiplication of many types of viruses, including hepatitis C virus.
Estonian: Ribavirin BioPartners peatab mitut tüüpi viiruste, sealhulgas C-hepatiidi viiruse paljunemist.
English: • had a previous serious heart condition or have cardiac disease.
Estonian: • on eelnevalt esinenud tõsine südameseisund või südamehaigus.
English: 2 tablets in the morning and 2 tablets in the evening 2 tablets in the morning and 3 tablets in the evening 3 tablets in the morning and 3 tablets in the evening 3 tablets in the morning and 4 tablets in the evening
Estonian: 2 tabletti hommikul ja 2 tabletti õhtul 2 tabletti hommikul ja 3 tabletti õhtul 3 tabletti hommikul ja 3 tabletti õhtul 3 tabletti hommikul ja 4 tabletti õhtul
English: Elderly patients (≥ 65 years of age): Specific pharmacokinetic evaluations for elderly subjects have not been performed.
Estonian: Eakad patsiendid (≥ 65-aastased): Spetsiifilist farmakokineetilist uuringut eakatel patsientidel ei ole teostatud.
English: Children and adolescents weighing less than 47 kg: The use of Ribavirin BioPartners tablets is not recommended.
Estonian: Lapsed ja noorukid, kes kaaluvad vähem kui 47 kg: Ribavirin BioPartners'i tablettide kasutamine ei ole soovitatav.
English: A total of 118 patients were enrolled: 57 % male, 80 % Caucasian, and 78 % genotype 1, 64 %  12 years of age.
Estonian: Kokku osales 118 patsienti: 57% meessoost, 80% valge rassi esindajaid, 78% genotüübiga 1 ja 64% ≤ 12 aastased.
English: If you have any questions about the dose, ask your doctor.
Estonian: Kui teil on annuse kohta küsimusi, küsige oma arstilt.
English: - Patients with severe, debilitating medical conditions.
Estonian: - Raske nõrgestava üldhaigusega patsiendid.
English: Treatment should be initiated, and monitored, by a physician experienced in the management of chronic hepatitis C.
Estonian: Ravi peab alustama ja jälgima arst, kellel on kogemused kroonilise hepatiit C patsientidega.
English: You should brush your teeth thoroughly twice daily and have regular dental examinations.
Estonian: Te peate oma hambaid hoolikalt harjama kaks korda päevas ning käima regulaarselt hambaarsti juures kontrollis.
English: For children and adolescents weighing less than 47 kg a solution formulation is available.
Estonian: Laste ja noorukite jaoks, kes kaaluvad vähem kui 47 kg, on saadaval lahuse ravimvorm.
English: Consideration should be given to replacing zidovudine in a combination anti-retroviral treatment (ART) regimen if this is already established.
Estonian: Tuleb kaaluda zidovudiini asendamist juba välja töötatud antiretroviraalse kombinatsioonravi (ART) skeemis.
English: Patients with substance use/abuse:
Estonian: Uimastavaid aineid kasutavad/kuritarvitavad patsiendid:
English: Patients should brush their teeth thoroughly twice daily and have regular dental examinations.
Estonian: Patsiendid peavad oma hambaid hoolikalt harjama kaks korda päevas ning käima regulaarselt hambaarsti juures kontrollis.
English: The following side effects have been reported with children and adolescents taking ribavirin and
Estonian: Järgnevatest kõrvaltoimetest on teatatud lastel ja noorukitel, kes võtavad ribaviriini ja
English: Population pharmacokinetic analysis was performed using sparsely sampled serum concentration values from four controlled clinical trials.
Estonian: Populatsiooni farmakokineetiline analüüs teostati kasutades neljast kontrollitud kliinilisest uuringust juhuslikult võetud seerumi kontsentratsiooni väärtusi.
English: Ribavirin clinical trials in children and adolescents:
Estonian: Ribaviriini kliinilised uuringud lastel ja noorukitel:
English: Any patient complaining of decrease or loss of vision must have a prompt and complete eye examination.
Estonian: Kõikidele patsientidele, kes kaebavad nägemise vähenemise või kadumise üle, tuleb teha kiire ja täielik silmauuring.
English: *AUC12 (ng.hr/ml) for Ribavirin; AUC0-24 (IU.hr/ml) for interferon alfa-2b
Estonian: *AUC12 (ng.h/ml) ribaviriini; AUC0-24 (RÜ.h/ml) interferoon alfa-2b jaoks
English: do not drive or use machines if you become tired, sleepy, or confused from this treatment.
Estonian: Seetõttu ärge juhtige autot ega kasutage masinaid, kui see ravi väsitab teid, tekitab unisust või segasust.
English: Long-term efficacy data - Children and adolescents A five-year long-term, observational, follow-up study enrolled 97 paediatric chronic hepatitis C patients after treatment in two previously mentioned multicentre trials.
Estonian: Pika-ajalise efektiivsuse andmed - lapsed ja noorukid Viieaastane pikaajaline jälgiv jätku-uuring hõlmas 97 pediaatrilist kroonilise C-hepatiidiga patsienti pärast ravi kahes varem nimetatud multitsentrilises uuringus.
English: Pharmacotherapeutic group: Direct acting antivirals, nucleosides and nucleotides (excl. reverse transcriptase inhibitors), ATC code: J05AB04.
Estonian: Farmakoterapeutiline grupp: Otseselt toimivad viirusevastased ained, nukleosiidid ja nukleotiidid (v.a pöördtranskriptaasi inhibiitorid), ATC-kood: J05AB04.
English: Cardiac status must be assessed before start of therapy and monitored clinically during therapy; if any deterioration occurs, therapy must be
Estonian: Südame seisundit tuleb hinnata enne ravi algust ja jälgida kliiniliselt ravi jooksul; kui ilmneb mingi halvenemine tuleb ravi lõpetada (vt